IRVINE, Calif., Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the U.S. Food and ...

In a bid to strengthen its position in predictive analytics, Edwards Lifesciences CorporationEW, has recently announced the approval of De Novo request from the FDA for the Acumen Hypotension ...

Blood pressure monitors have already gone “smart,” with apps, smartwatches and other sleek wearables now able to take readings at least as accurate as traditional upper arm cuffs—if not more so. Now, ...

IRVINE, Calif., June 1, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S.

Medical equipment major Edwards Lifesciences Corporation EW recently announced the receipt of CE Mark for its Acumen Hypotension Probability Indicator (HPI). The device is an advanced technology that ...

Edwards Lifesciences Corp. has won the FDA’s nod for its Acumen hypotension prediction index (HPI) software with the Acumen IQ finger cuff. Prior to receiving this 510(k) clearance, the low blood ...

Edwards Lifesciences Corporation, a global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced it received CE Mark for its Acumen Hypotension ...

In Europe, of the 2.5 million patients undergoing high-risk surgery annually, one in four develops serious postoperative complications. 1,2 Intraoperative hypotension (critical drops in blood pressure ...

Edwards Lifesciences Corp.’s foray into smart recovery technologies already allowed physicians to foresee when critical care patients are at risk of low blood pressure events. Now, for the first time, ...

MILAN, Oct. 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today ...